考古体纳米载体在口服后改善了万科米的药理动力学和生物可用性
Viktor Sedlmayr1, Julian Quehenberger2, David Wurm2
1Heidelberg University, Institute of Pharmacy and Molecular Biotechnology, Im Neuenheimer Feld 329, 69120 Heidelberg, Germany; NovoArc GmbH, Pottendorfer Straße 23-25, 4, 4-1, 1120 Vienna, Austria.
概括
考古体,纳米载体与考古脂质,显著提高口服万科米辛的生物可用性. 这一突破使得通常静脉注射的抗生素可以通过口服输送,改善了患者的坚持和治疗疗效.
科学领域:
- 纳米技术 纳米技术
- 药理学 药理学是指药理学的学科.
- 微生物学 微生物学
背景情况:
- 范科米辛是格拉姆阳性感染的关键抗生素,通常是静脉注射,因为口服吸收不良.
- 口服提供了更好的患者坚持,但受到低粘膜运输的限制,限制其用于肠道感染.
研究的目的:
- 为了研究使用古物脂质的纳米载体 - - 考古体的潜力,以提高香素的口服生物可用性.
- 评估通过古体配方输送的万科米辛的药理动力学和安全性.
主要方法:
- 范科米辛被封装在由古脂提取物 (ALE) 和纯化卡尔达古 (GDGT) 制成的古体中.
- 在雄性Wistar大鼠中进行了药理动力学研究,比较了口服的古遗体香草素与自由的香草素.
- 测量了全身暴露,血药物度和口服生物利用率 (AUC).
主要成果:
- 考古体的万科米辛配方显示显著增强了全身暴露和延长了循环时间.
- 口服生物可用性增加了9倍与GDGT脂质体和4倍与ALE脂质体相比,相比自由的vancomycin.
- 考古体的配方表现出高的生物相容性.
结论:
- 基于古物脂质的纳米载体 (古物质体) 显示出显著的前景,改善了科米辛的口服输送.
- 这种药物输送系统可以使目前仅限于静脉注射的治疗药物口服,提高患者的服药性和治疗可及性.
相关概念视频
Factors Affecting Dissolution: Particle Size and Effective Surface Area
1.1K
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
1.1K
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
269
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
269
Factors Influencing Drug Absorption: Presystemic Elimination
365
The pharmacokinetic journey of oral drugs begins with a crucial first pass through the hepatic portal system, called the first-pass effect. This first pass significantly impacts bioavailability — the proportion of a drug that enters systemic circulation and is available for therapeutic action. The primary route sees the drug absorbed by intestinal membranes and then shunted to the liver via the hepatic portal vein. Here, pre-systemic elimination occurs as drugs face metabolism or biliary...
365
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
4.6K
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
4.6K
Routes of Drug Administration: Enteral
4.5K
Medications can be administered through the enteral route using liquids, capsules, or tablets.
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...
4.5K
Non-Oral Extravascular Drug Absorption Routes
306
Non-oral extravascular routes, which encompass sublingual, buccal, topical, intramuscular, and inhalation methods, primarily utilize passive diffusion to transport drugs into the systemic circulation. The absorption rates and effectiveness of these routes depend on the drug's physicochemical properties, as well as the patient's anatomical and pathophysiological state.
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...
306


